This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Russian drug from coronavirus ready to purchase in 50 countries
The Russian Direct Investment Fund (RDIF) and the ChemRar Group almost doubled the production of the Russian drug Avonavir coronavirus. Now the drug is being delivered to the regions of the country, but 50 countries are also interested in importing.
According to the RDIF press service, initially it was planned to launch the release of about 60 thousand courses of therapy for coronavirus in June, but production was increased to 100 thousand courses only in the first month. The same production volume is planned for July.
The drug was delivered to 35 regions of Russia and to Belarus. Also, the party will be sent to Kazakhstan. Negotiations are underway on deliveries to Latin America, the CIS and the Middle East. In order to expand Avifavir's export deliveries and satisfy the demand in the regions, the joint company RDIF and KhimRar will increase output threefold - up to 300 thousand courses per month.
The drug received registration May 29, June 3 it was included in the last, seventh edition of the guidelines for the treatment of coronavirus. According to the Director General of the RDIF, Kirill Dmitriev, Avifavir today is one of the most effective anti-coronavirus drugs in the world. Russians get it for freefirst batches already sent to the country's hospitals.